{"id":"https://openalex.org/W2328979501","doi":"https://doi.org/10.1158/1538-7445.am2012-3115","title":"Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors","display_name":"Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2328979501","doi":"https://doi.org/10.1158/1538-7445.am2012-3115","mag":"2328979501"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-3115","doi":"https://doi.org/10.1158/1538-7445.am2012-3115","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-3115","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001949379","display_name":"Judith Michels","orcid":"https://orcid.org/0000-0002-9640-0222","observed_orcids":["https://orcid.org/0000-0002-9640-0222"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Judith Michels","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067656240","display_name":"Ilio Vitale","orcid":"https://orcid.org/0000-0002-5918-1841","observed_orcids":["https://orcid.org/0000-0002-5918-1841"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ilio Vitale","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056768522","display_name":"Oliver Kepp","orcid":"https://orcid.org/0000-0002-6081-9558","observed_orcids":["https://orcid.org/0000-0002-6081-9558"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Oliver Kepp","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074355427","display_name":"Laura Senovilla","orcid":"https://orcid.org/0000-0001-6887-2436","observed_orcids":["https://orcid.org/0000-0001-6887-2436"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laura Senovilla","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033733948","display_name":"Ken Andre\u0301 Olaussen","orcid":"https://orcid.org/0000-0002-3115-8914","observed_orcids":["https://orcid.org/0000-0002-3115-8914"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ken Andre\u0301 Olaussen","raw_affiliation_strings":["2Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021624793","display_name":"Jean\u2010Charles Soria","orcid":"https://orcid.org/0000-0001-9597-0701","observed_orcids":["https://orcid.org/0000-0001-9597-0701"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Soria","raw_affiliation_strings":["2Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044366070","display_name":"Maria Castedo","orcid":"https://orcid.org/0000-0001-6855-3451","observed_orcids":["https://orcid.org/0000-0001-6855-3451"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maria Castedo","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075296559","display_name":"Guido Kroemer","orcid":"https://orcid.org/0000-0002-9334-4405","observed_orcids":["https://orcid.org/0000-0002-9334-4405"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Guido Kroemer","raw_affiliation_strings":["1INSERM U848, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U848, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"3115","last_page":"3115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7289999723434448},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8930000066757202},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pj34","display_name":"PJ34","score":0.8700000047683716},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.7829999923706055},{"id":"https://openalex.org/keywords/parp2","display_name":"PARP2","score":0.972000002861023},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.7540000081062317},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.550000011920929},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.8510000109672546}],"concepts":[{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.7799394130706787},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.7216696739196777},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6518188118934631},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5802203416824341},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.5241925120353699},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.519515872001648},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5100944638252258},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.49033451080322266},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4850315451622009},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.46736380457878113},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45584625005722046},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4335162937641144},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.30154943466186523},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.21773117780685425},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14479950070381165},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.094058096408844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-3115","doi":"https://doi.org/10.1158/1538-7445.am2012-3115","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-3115","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1989389011","https://openalex.org/W3009707110","https://openalex.org/W2916125826","https://openalex.org/W2514291160","https://openalex.org/W2476665479","https://openalex.org/W2549651109","https://openalex.org/W2589593521","https://openalex.org/W3013942639","https://openalex.org/W2588625168","https://openalex.org/W2157060862"],"abstract_inverted_index":{"Abstract":[0],"Chemical":[1],"inhibitors":[2,46,81,283],"of":[3,22,68,79,89,96,105,139,142,171,210,226,237,249,261,288,316,333,338],"poly(ADP)ribose":[4],"(PAR)":[5],"polymerases":[6],"(PARP)":[7],"have":[8],"generated":[9],"raising":[10],"expectations":[11],"in":[12,27,155],"cancer":[13,123,158,161],"treatment,":[14],"either":[15],"as":[16,61,181,183],"monotherapeutic":[17],"agents":[18],"for":[19,55,86,246,299,342],"the":[20,71,77,87,94,103,111,115,140,223,234,247,286,314,334,339],"therapy":[21],"tumors":[23,63],"that":[24,44,92,132,164,195,221,273,310],"are":[25,47,135,165,275],"deficient":[26],"DNA":[28,211],"repair":[29],"by":[30,167,175,190,215,241,267,278,297,322],"homologous":[31],"recombination,":[32],"or":[33,257],"combined":[34],"with":[35,177,192,201,205,218,244],"DNA-damaging":[36],"compounds.":[37],"Results":[38],"from":[39],"early":[40],"clinical":[41],"trials":[42],"suggest":[43],"PARP":[45,80,97,109,128,146,172,185,202,207,279,282,293,311,323],"well":[48,182],"tolerated,":[49],"and":[50,57,114,159,229,252,263,269],"would":[51],"be":[52],"particularly":[53],"useful":[54],"BRCA1-":[56],"BRCA2-mutated":[58],"tumors.":[59],"However,":[60],"these":[62,153],"constitute":[64],"a":[65,136,178],"minor":[66],"fraction":[67],"all":[69],"cancers,":[70],"main":[72],"challenge":[73],"is":[74],"to":[75,82,145,151,319],"extend":[76],"efficacy":[78],"BRCA-proficient":[83],"tumors,":[84],"calling":[85],"need":[88],"reliable":[90],"biomarkers":[91],"predict":[93],"efficiency":[95],"inhibitor-based":[98],"therapy.":[99],"Here,":[100],"we":[101],"report":[102],"effects":[104,260],"two":[106],"chemically":[107],"distinct":[108],"inhibitors,":[110,203],"phenanthridinone":[112],"PJ34":[113,262],"4-methoxy-carbazole":[116],"derivate":[117],"CEP8983,":[118],"on":[119,302],"non-small":[120],"cell":[121,162,231,258],"lung":[122],"(NSCLC)":[124],"cells":[125,144,204,318],"exhibiting":[126,291],"increased":[127,169,292],"activity.":[129],"We":[130,148],"found":[131],"PAR":[133],"polymers":[134],"predictive":[137],"marker":[138],"sensitivity":[141],"NSCLC":[143,289,317],"inhibitors.":[147,324],"were":[149,265],"able":[150],"confirm":[152],"findings":[154],"mesothelioma,":[156],"cervical":[157],"ovarian":[160],"lines":[163],"characterized":[166],"constitutively":[168],"expression":[170],"(as":[173,188,213,239,295],"monitored":[174,240],"immunoblotting":[176,191],"PARP1-specific":[179],"antibody)":[180],"enhanced":[184],"enzymatic":[186],"activity":[187,294],"detected":[189],"an":[193,219],"antibody":[194,220],"recognizes":[196,222],"poly(ADP)ribosylated":[197,300],"proteins).":[198],"Upon":[199],"treatment":[200],"hyperactivated":[206],"exhibited":[208],"signs":[209],"damage":[212],"assessed":[214],"immunofluorescence":[216,242],"microscopy":[217,243],"phosphorylated":[224],"form":[225],"histone":[227],"2AX)":[228],"underwent":[230],"death":[232],"via":[233],"intrinsic":[235],"pathway":[236],"apoptosis":[238,320],"antibodies":[245],"detection":[248],"cytochrome":[250],"c":[251],"active":[253],"caspase-3).":[254],"The":[255],"chemosensitizing":[256],"death-inducing":[259],"CEP8983":[264],"mimicked":[266],"PARP1-":[268],"PARP2-specific":[270],"siRNAs,":[271],"suggesting":[272],"they":[274],"indeed":[276],"mediated":[277],"inhibition.":[280],"Moreover,":[281],"efficiently":[284],"reduced":[285],"growth":[287],"xenografts":[290],"evaluated":[296],"immunohistochemistry":[298],"proteins":[301],"paraffin":[303],"embedded":[304],"xenografts).":[305],"Altogether,":[306],"our":[307],"results":[308],"indicate":[309],"overactivation":[312],"reflects":[313],"susceptibility":[315],"induction":[321],"Citation":[325],"Format:":[326],"{Authors}.":[327],"{Abstract":[328],"title}":[329],"[abstract].":[330],"In:":[331],"Proceedings":[332],"103rd":[335],"Annual":[336],"Meeting":[337],"American":[340],"Association":[341],"Cancer":[343,354],"Research;":[344],"2012":[345],"Mar":[346],"31-Apr":[347],"4;":[348],"Chicago,":[349],"IL.":[350],"Philadelphia":[351],"(PA):":[352],"AACR;":[353],"Res":[355],"2012;72(8":[356],"Suppl):Abstract":[357],"nr":[358],"3115.":[359],"doi:1538-7445.AM2012-3115":[360]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}